MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Home・Akcijų sąrašas・Essa Pharma Inc

Essa Pharma Inc

Uždarymo kaina

0.19 -5

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.19

Max

0.19

Pagrindiniai rodikliai
By Trading Economics
Pajamos	2.4M -4M
Dividendų pajamingumas	87.56
Darbuotojai	35
EBITDA	1.4M -5M

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	87.56% 3.00%

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-75M 9.5M
Ankstesnė atidarymo kaina	5.19
Ankstesnė uždarymo kaina	0.19

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

1.7 / 1.72 Palaikymas ir pasipriešinimas

Essa Pharma Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-15 23:25; UTC

Pagrindinės rinkos jėgos

Salesforce Rises on New FY30 Financial Targets

2025-10-15 18:52; UTC

Uždarbis

Pagrindinės rinkos jėgos

Prologis Shares Gain on Raised Outlook, Data Center Growth

2025-10-15 18:30; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Software to Buy U.K.'s Tecvia Holding

2025-10-15 17:19; UTC

Įsigijimai, susijungimai, perėmimai

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

2025-10-15 17:11; UTC

Įsigijimai, susijungimai, perėmimai

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

2025-10-15 23:48; UTC

Rinkos pokalbiai

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

2025-10-15 23:38; UTC

Rinkos pokalbiai

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

2025-10-15 22:37; UTC

Rinkos pokalbiai

Economic Stars Are Aligning for RBA -- Market Talk

2025-10-15 21:44; UTC

Uždarbis

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

2025-10-15 20:50; UTC

Rinkos pokalbiai

Uždarbis

Financial Services Roundup: Market Talk

2025-10-15 20:44; UTC

Įsigijimai, susijungimai, perėmimai

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

2025-10-15 20:44; UTC

Įsigijimai, susijungimai, perėmimai

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

2025-10-15 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

2025-10-15 20:34; UTC

Uždarbis

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

2025-10-15 20:31; UTC

Įsigijimai, susijungimai, perėmimai

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

2025-10-15 20:17; UTC

Įsigijimai, susijungimai, perėmimai

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

2025-10-15 19:06; UTC

Uždarbis

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

2025-10-15 19:04; UTC

Rinkos pokalbiai

Oil Futures Post Back-to-Back Losses -- Market Talk

2025-10-15 18:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

2025-10-15 18:23; UTC

Uždarbis

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

2025-10-15 17:37; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

2025-10-15 17:34; UTC

Rinkos pokalbiai

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

2025-10-15 16:57; UTC

Uždarbis

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

2025-10-15 16:51; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Doesn't Disclose Financial Details

2025-10-15 16:50; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

2025-10-15 16:49; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

2025-10-15 16:48; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

2025-10-15 16:48; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

2025-10-15 16:47; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Buys Ikerian

2025-10-15 16:34; UTC

Rinkos pokalbiai

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Akcijų palyginimas

Kainos pokytis

Essa Pharma Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių Essa Pharma Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

1.7 / 1.72Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.